bevacizumab,atezolizumab
roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'atezo', 'bev/', 'rectal', 'colorectal']
#asco2023 from dr. c. antoniotti: update on folfoxiri/bev/atezo for 1st line mcrc with improved pfs (hr = 0.71) suggesting #immunoscore high pts appeared to fare better. the splay appears to occur late and no difference for os (~80% had 2nd line treatment). thoughts? #colorectal 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations